Abbott Laboratories

ABT | NYSE

Price Alert Chart Builder DCF Calculator

$106.20

+$1.63 (+1.56%)

At close: Oct 30, 2026, 4:02 PM ET

$106.00

-$0.20 (-0.19%)

Pre-market: Nov 2, 2026, 7:26 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Market Data

Market Cap $183.77B

Enterprise Value $210.77B

Beta 0.58

Average Volume 9.92M

Shares Outstanding (Diluted) 1.74B

Shares Change YoY -0.63%

Institutional Ownership 82.29%

Exchange NYSE

ISIN US0028241000

Price Performance

Price Change 1M 7.5%

Price Change 3M 0.5%

Price Change 6M 18.7%

Price Change YTD -15.2%

Price Change 1Y -14.1%

Price Change 3Y 12.3%

Price Change 5Y -17.6%

1M CAGR (ann.) 4.1%

1Y CAGR (ann.) -12.5%

5Y CAGR (ann.) -1.5%

All-Time CAGR 12.2%

Valuation

PE Ratio 39.33

Forward PE 17.80

PEG Ratio -0.59

Forward PEG 5.55

PS Ratio 3.81

Forward PS 3.40

PB Ratio 3.60

P/FCF Ratio 21.07

P/Adj. FCF Ratio 22.97

P/OCF Ratio 18.63

EV/Sales 4.37

EV/EBIT 29.38

EV/EBITDA 21.71

EV/FCF 24.17

Earnings Yield 2.5%

FCF Yield 4.8%

Adj. FCF Yield 4.3%

Financial Health

Net Debt $27.01B

Total Debt $32.61B

Cash & Short-Term Investments $5.6B

Total Assets $109.22B

Current Ratio 1.38

Quick Ratio 0.97

Debt / Equity Ratio 0.64

Debt / EBITDA 3.36

Debt / FCF 3.74

OCF / Debt 0.30

Interest Coverage 8.26

Altman Z-Score 3.29

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 57.1%

Operating Profit Margin 15.2%

EBITDA Margin 20.1%

Net Profit Margin 9.8%

FCF Margin 18.1%

Adj. FCF Margin 16.6%

SBC / Revenue 1.5%

SBC Impact (per share) -8.2%

Returns

Return on Assets 4.3%

Return on Equity 9.1%

Return on Invested Capital 5.6%

Return on Capital Employed 8.0%

Return on Tangible Assets 8.3%

Historical Growth (CAGR)

Revenue CAGR 3Y 6.5%

Revenue CAGR 5Y 2.6%

Revenue CAGR 10Y 8.8%

EPS CAGR 3Y -2.8%

EPS CAGR 5Y -7.7%

EPS CAGR 10Y 11.4%

FCF CAGR 3Y 16.7%

FCF CAGR 5Y 0.2%

FCF CAGR 10Y 17.8%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 21

EPS Growth Next 3Y 38.7%

Revenue Growth Next 3Y 8.4%

Earnings Date Jan 28, 2027

EPS Estimate (next Q) $1.64

EPS Growth Est (next Q) 9.3%

Revenue Est (next Q) $13.22B

Revenue Growth Est (next Q) 15.3%

Fair Value Estimates

Graham Number $42.53

Graham Upside -60.0%

Lynch Fair Value $13.50

Lynch Upside -87.3%

Price Target $121.36

Price Target Upside 14.3%

Cash Flow

Operating Cash Flow $9.91B

Free Cash Flow $8.72B

Adj. Free Cash Flow $8B

FCF Per Share $5.02

OCF Per Share $5.70

OCF/S Ratio 20.5%

Income Statement

Revenue $48.23B

Gross Profit $27.55B

Operating Income $7.35B

EBITDA $9.71B

Net Income $4.7B

EPS (Diluted) $2.70

Revenue / Employee $419.38K

Profit / Employee $40.88K

Employees 115,000

Dividends

Annual Dividend $2.52

Dividend Yield 2.37%

Payout Ratio 93.3%

FCF Payout Ratio 48.9%

Adj. FCF Payout Ratio 53.3%

Dividend Growth (YoY) 6.8%

Pay Frequency Quarterly

Ex-Dividend Date Oct 15, 2026